This inventor holds 1 USPTO granted patent. Top assignee: Shangdong Intech Medical Technology Co., Ltd. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: Innovations in Coronary Stents by Xiaoxin Shang
Introduction
Xiaoxin Shang is a notable inventor based in Shandong, China. He has made significant contributions to the field of medical technology, particularly in the development of coronary stents. His innovative approach has led to advancements that enhance the effectiveness of interventional therapies for coronary diseases.
Latest Patents
Xiaoxin Shang holds a patent for a coronary stent with an asymmetric drug releasing controlled coating. This invention is designed to improve the treatment of coronary disease by utilizing a multi-layered coating that releases drugs in a controlled manner. The stent consists of a bare stent and a coating that includes both a drug and a carrier. The drug concentration increases from the outer layer to the inner layer, allowing for a tailored therapeutic effect. The drugs used may include taxol, rapamycin, heparin, and docetaxel, among others. The innovative design of this drug-coated stent aims to prevent vascular restenosis and reduce the occurrence of late thrombosis.
Career Highlights
Xiaoxin Shang is associated with Shandong Intech Medical Technology Co., Ltd., where he continues to work on groundbreaking medical technologies. His expertise in the field has positioned him as a key player in the development of advanced medical devices.
Collaborations
Xiaoxin has collaborated with notable colleagues such as Junbo Ge and Shenguo Wang. Their combined efforts contribute to the ongoing advancements in medical technology and innovation.
Conclusion
Xiaoxin Shang's contributions to the field of coronary stents exemplify the importance of innovation in medical technology. His patented designs not only enhance treatment efficacy but also prioritize patient safety and comfort.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile